PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Refractory Viral Infections, National Center for Global Health and Medicine (NCGM) Research Institute, Tokyo, Japan. kmaeda@ri.ncgm.go.jp.\', \'Department of Refractory Viral Infections, National Center for Global Health and Medicine (NCGM) Research Institute, Tokyo, Japan.\', \'Disease Control and Prevention Center (DCC), NCGM, Tokyo, Japan.\', \'AIDS Clinical Center, NCGM, Tokyo, Japan.\', \'Respiratory Medicine, NCGM Center Hospital, Tokyo, Japan.\', \'Department of Refractory Viral Infections, National Center for Global Health and Medicine (NCGM) Research Institute, Tokyo, Japan. hmitsuya@hosp.ncgm.go.jp.\', \'Experimental Retrovirology Section, HIV and AIDS Malignancy Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. hmitsuya@hosp.ncgm.go.jp.\', \'Department of Clinical Sciences, Kumamoto University Hospital, Kumamoto, Japan. hmitsuya@hosp.ncgm.go.jp.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1038/s41598-021-84733-5
?:hasPublicationType
?:journal
  • Scientific reports
is ?:pmid of
?:pmid
?:pmid
  • 33692457
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.533
?:rankingScore_hIndex
  • 122
?:title
  • Neutralization of SARS-CoV-2 with IgG from COVID-19-convalescent plasma.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all